Gilead Sciences Inc. Stock Performance
as on March 20, 2026 at 2:08 am IST
Day's Low
Day's High
$140.81$142.09
0.42%
Downside
0.49%
Upside
52 Week's Low
52 Week's High
$93.37$157.2933.97%
Downside
11.24%
Upside
Gilead Sciences Inc. share price movements today
- Previous Close
- $141.29
- Open
- $141.41
- Volume
- 624.5K
- Day's Low - High
- $140.81 - $142.09
- 52 Week Low - High
- $93.37 - $157.29
Gilead Sciences Inc. Historical Returns
- 1 Month Return
- -6.5 %
- 3 Month Return
- + 13.68 %
- 1 Year Return
- + 31.42 %
- 3 Year Return
- + 82.76 %
- 5 Year Return
- + 119.19 %
Gilead Sciences Inc. Stock Fundamentals & Key Indicators
Check Gilead Sciences Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$179.3B
EPS (TTM)
8.6802
Dividend Yield
3.74%
Quarterly Earnings Growth YOY
0.23%
PE Ratio (TTM)
21.27
Industry PE ratio
17.711025641025643
PEG Ratio
0.405
EBITDA
14.6B
Revenue (TTM)
29.4B
Profit Margin
28.90%
Return On Equity TTM
40.66%
Gilead Sciences Inc. Stock Valuation
Track how Gilead Sciences Inc. P/E has moved over time to understand its valuation trends.
Gilead Sciences Inc. in the last 5 years
Lowest (7.99x)
September 30, 2021
Industry (17.71x)
March 19, 2026
Today (21.27x)
March 19, 2026
Highest (19.53x)
December 31, 2024
Today’s Price to Earnings Ratio: 21.27x
Gilead Sciences Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Gilead Sciences Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| HOLD | $179.3B | 119.19% | 21.27 | 28.90% | |
| BUY | $296.6B | 282.89% | 29.25 | 17.41% | |
| BUY | $832.7B | 398.16% | 40.49 | 31.67% | |
| BUY | $573.8B | 48.26% | 21.61 | 28.46% | |
| BUY | $388.6B | 101.45% | 92.73 | 6.91% |
Stock Returns calculator for Gilead Sciences Inc. Stock including INR - Dollar returns
The Gilead Sciences Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Gilead Sciences Inc. investment value today
Current value as on today
₹1,39,485
Returns
₹39,485
(+39.48%)
Returns from Gilead Sciences Inc. Stock
₹31,523 (+31.52%)
Dollar Returns*
₹7,962 (+7.96%)
Analyst Recommendation on Gilead Sciences Inc. Stock
Based on 38 analysts
47.37%
Buy
52.63%
Hold
0.00%
Sell
Based on 38 analysts, 52.63% of analysts recommend a 'HOLD' rating for Gilead Sciences Inc.. Average target price of $157.43
Gilead Sciences Inc. Share Price Target
Get share price movements and forecasts by analysts on Gilead Sciences Inc..
What analysts predicted
10.18%UPSIDE
Target Price
$157.43
Current Price
$141.4
Analyzed by
38 Analysts
Target
$157.43
Gilead Sciences Inc. target price $157.43, a slight upside of 10.18% compared to current price of $141.4. According to 38 analysts rating.
Gilead Sciences Inc. Stock’s Investor Sentiment and Interest
Search interest for Gilead Sciences Inc. Stock has decreased by -32% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Gilead Sciences Inc. Quarterly Profit & Loss
All numbers in Millions USD
Gilead Sciences Inc. Annual Profit & Loss
All numbers in Millions USD
Gilead Sciences Inc. Quarterly Cash Flow
All numbers in Millions USD
Gilead Sciences Inc. Annual Cash Flow
All numbers in Millions USD
Mutual Funds that own Gilead Sciences Inc. Stock
Check out the Mutual Funds with significant holdings in Gilead Sciences Inc..
Funds | Holdings | Shares Held |
|---|---|---|
 Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth | 1.31194% | 1694 |
 Motilal Oswal S&P 500 Index Fund Direct Growth | 0.31047% | 9286 |
 ICICI Prudential NASDAQ 100 Index Fund Direct Growth | 0.99277% | 20525 |
Global Institutional Holdings in Gilead Sciences Inc.
Gilead Sciences Inc. News & Key Events
Today's Timeline - 17 March
Tue, 02:57 PM
-CFO highlights YEZTUGO launch success and Arcellx acquisition for enhanced cell therapy.
Tue, 03:41 PM
-Gilead discusses long-acting HIV treatments and Livdelzi expansion, aiming for six-month dosing regimens.
Insights on Gilead Sciences Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Gilead Sciences Inc. has shown consistent revenue growth over the last four quarters. The company's revenue rose from $6.66 billion to $7.92 billion, resulting in an average increase of 5.6% each quarter.
- POSITIVE IMPACT
Price Rise
In the last 3 months, GILD stock has moved up by 13.7%
NO EFFECTAgainst Peers
In the last 3 years, ASTRAZENECA PLC has given 187.2% return, outperforming this stock by 104.4%
- NO EFFECT
Against Peers
In the last 1 year, ASTRAZENECA PLC has given 146.9% return, outperforming this stock by 115.5%
NEGATIVE IMPACTProfit Down
Gilead Sciences Inc. has experienced a decline in net profit over the last two quarters. The company's net profit fell from $3.05 billion to $2.18 billion, representing an average decrease of 28.5% per quarter.
About Gilead Sciences Inc.
| Organisation | Gilead Sciences Inc. |
| Headquarters | 333 Lakeside Drive, Foster City, CA, United States, 94404 |
| Industry | Health Technology |
| CEO | Mr. Daniel P. O'Day |
| E-voting on shares | Click here to vote |
Key Management of Gilead Sciences Inc.
Name | Title |
|---|---|
Dr. Linda Slanec Higgins Ph.D. | Senior Vice President of Research, Innovation & Portfolio |
Dr. Flavius Martin M.D. | Executive Vice President of Research |
Mr. Daniel P. O'Day | Chairman & CEO |
Mr. Andrew D. Dickinson | Chief Financial Officer |
Ms. Keeley Wettan | Executive VP and General Counsel of Legal & Compliance |
Ms. Jyoti K. Mehra | Executive Vice President of Human Resources |
Ms. Janet Dorling | Senior Vice President of Intercontinental Region & Global Patient Solutions |
Ms. Johanna Mercier | Chief Commercial & Corporate Affairs Officer |
Ms. Erin E. Burkhart | SVP, Controller & Principal Accounting Officer |
Ms. Jacquie Ross C.F.A. | Senior Vice President of Treasury and Investor Relations |
FAQs
What is Gilead Sciences Inc. share price today?
Gilead Sciences Inc. share price today is $141.4 as on . Gilead Sciences Inc. share today touched a day high of $142.09 and a low of $140.81.
What is the 52 week high and 52 week low for Gilead Sciences Inc. share?
Gilead Sciences Inc. share touched a 52 week high of $157.29 on and a 52 week low of $93.37 on . Gilead Sciences Inc. stock price today i.e. is trending at $141.4,which is 10.10% down from its 52 week high and 51.44% up from its 52 week low.
What is Gilead Sciences Inc.'s market capitalisation today?
Gilead Sciences Inc. market capitalisation is $0.18T as on .
How to invest in Gilead Sciences Inc. Stock (GILD) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Gilead Sciences Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Gilead Sciences Inc. Shares that will get you 0.0106 shares as per Gilead Sciences Inc. share price of $141.4 per share as on March 19, 2026 at 8:38 pm IST.
What is the minimum amount required to buy Gilead Sciences Inc. Stock (GILD) from India?
Indian investors can start investing in Gilead Sciences Inc. (GILD) shares with as little as ₹93.193 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹931.93 in Gilead Sciences Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Gilead Sciences Inc. share’s latest price of $141.4 as on March 19, 2026 at 8:38 pm IST, you will get 0.0707 shares of Gilead Sciences Inc.. Learn more about
fractional shares .
What are the returns that Gilead Sciences Inc. has given to Indian investors in the last 5 years?
Gilead Sciences Inc. stock has given 119.19% share price returns and 27.41% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?